COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.
Participants Needed for Asthma Prevention Study
January 22, 2019
The Children's National IMPACT DC team is conducting the ORBEX study to assess the effectiveness of a medication in the prevention of infant wheezing. We are looking for healthy babies age 5-17 months who are at risk for developing asthma (as defined by having a parent or sibling over 4 years of age with asthma or eczema).
For more information, visit breatheeasyearly.info or contact: